Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of Famitinib in Healthy Chinese Adults
NCT04616716Phase 1Completed
- Sponsor
- Hengrui
- Start
- May 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of famitinib in solid tumor (6 arms), sponsored by Hengrui. Primary endpoints: Maximum Plasma Concentration at Day 19, Area Under the Curve to the Last Measurable Time Point at Day 19 and 1 more. Started May 2020; status: completed.
02
Drugs
famitinib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04616716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04616716.